ASAT

Intel Launches World’s First Systems Foundry Designed for the AI Era

Retrieved on: 
Wednesday, February 21, 2024
Software, Networks, Internet, Hardware, Artificial Intelligence, Data Management, Technology, Semiconductor, Ansys, Intel, INTC, Multimedia, Socs, AI, Silicon, 3D, Growth, X86, Credit, Commerce, Synopsys, EDA, UMC, Ecosystem, ASAT, Arm, Electricity, IP, OpenAI, Microsoft, Intellectual property, GHG, 3-T

Intel Corp. (INTC) today launched Intel Foundry as a more sustainable systems foundry business designed for the AI era and announced an expanded process roadmap designed to establish leadership into the latter part of this decade.

Key Points: 
  • Intel Corp. (INTC) today launched Intel Foundry as a more sustainable systems foundry business designed for the AI era and announced an expanded process roadmap designed to establish leadership into the latter part of this decade.
  • (Credit: Intel Corporation)
    The announcements were made at Intel’s first foundry event, Intel Foundry Direct Connect, where the company gathered customers, ecosystem companies and leaders from across the industry.
  • “This is creating an unprecedented opportunity for the world’s most innovative chip designers and for Intel Foundry, the world’s first systems foundry for the AI era.
  • That’s why we are so excited to work with Intel Foundry, and why we have chosen a chip design that we plan to produce on Intel 18A process.”
    Intel Foundry has design wins across foundry process generations, including Intel 18A, Intel 16 and Intel 3, along with significant customer volume on Intel Foundry ASAT capabilities, including advanced packaging.

Vaccentis appoints Martin Munte as CEO and strengthens Board

Retrieved on: 
Tuesday, July 12, 2022
ASAT, Marketing, Leadership, Risk, CEO, Roche, Research, Policy, AstraZeneca, Therapy, Immune system, Board, Recurrence, Board of directors, Fine chemical, Management, Pharmaceutical industry, Amgen

Martin Munte held a series of senior roles at Amgen for 12 years, most recently as External Access Engagement Lead Europe.

Key Points: 
  • Martin Munte held a series of senior roles at Amgen for 12 years, most recently as External Access Engagement Lead Europe.
  • I am delighted to welcome Martin Munte to Vaccentis as our new CEO.
  • The expansion of our Board of Directors through the appointment of Marcel Frei, Subhasis Roy and myself will also add important skills to help Martin guide the further development of Vaccentis.
  • Our goal is to ensure that our innovative tailor made medicines for autologous patient treatment are consistently advanced and perfected on the combined basis of classical and complementary medicines, said Martin Munte, CEO.

NASA Administrator Statement on White House ASAT Announcement

Retrieved on: 
Tuesday, April 19, 2022
ASAT, Multimedia, NASA, Foreign policy of the Joe Biden administration, Risk, View, Communications satellite

WASHINGTON, April 19, 2022 /PRNewswire/ -- NASA Administrator Bill Nelson released this statement Tuesday following Vice President Kamala Harris' announcement the U.S. will not conduct destructive anti-satellite missile testing (ASAT):

Key Points: 
  • WASHINGTON, April 19, 2022 /PRNewswire/ -- NASA Administrator Bill Nelson released this statement Tuesday following Vice President Kamala Harris' announcement the U.S. will not conduct destructive anti-satellite missile testing (ASAT):
    "Fifteen years ago, China's military littered outer space with thousands of pieces of debris from a reckless ASAT missile test.
  • Just a few months ago, another destructive ASAT test by the Russian military threatened U.S. and European astronauts, Russian cosmonauts, and Chinese taikonauts in space, as well as scientific and commercial on-orbit assets.
  • "There is no doubt that human spaceflight and the future of the space environment are incompatible with destructive direct-ascent ASAT missile tests.
  • For more information on NASA and agency activities, visit:
    View original content to download multimedia: https://www.prnewswire.com/news-releases/nasa-administrator-statement-on...

China Lobaplatin Research Markets Report 2021: Sales 2016-2020, Major Manufacturers, Prices 2020-2021, Prospects 2021-2025 - ResearchAndMarkets.com

Retrieved on: 
Thursday, March 10, 2022
Pharmaceutical, Health, Oncology, Research report, Apoptosis, Incidence, The Different Company, China Energy Research Report, ASAT, Pollution, Acute leukemia, Dosage form, CMML, NMPA, DNA, Cell proliferation, Breast cancer, Chronic myelomonocytic leukemia, COVID-19, CAGR, Nedaplatin, Cisplatin, Squamous cell carcinoma, Animal, Motor vehicle

The "Research Report on China's Lobaplatin Market, 2021-2025" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Research Report on China's Lobaplatin Market, 2021-2025" report has been added to ResearchAndMarkets.com's offering.
  • According to the publisher's market research, there are five types of platinum-based antitumor drugs commonly used in China: first-generation cisplatin, second-generation carboplatin and nedaplatin, third-generation oxaliplatin and lobaplatin.
  • According to the publisher's market research, since its launch in China, lobaplatin showed an upward trend in sales volume and value from 2005 to 2019.
  • Prospects of China's Lobaplatin Market, 2021-2025
    2 Sales of Lobaplatin in China, 2016-2020
    2.3 Sales of Lobaplatin in China by Dosage Form, 2016-2020
    3 Analysis of Major Lobaplatin Manufacturers in China, 2020
    3.2 Hainan Changan International Pharmaceutical Co. Ltd
    4 Sales Price of Lobaplatin of Different Companies in China, 2020-2021
    4.1 Hainan Changan International Pharmaceutical Co.
    5 Prospects of China's Lobaplatin Market, 2021-2025
    View source version on businesswire.com: https://www.businesswire.com/news/home/20220310005712/en/

BridgeComm Names Rich Tortorelli as Chief Systems Engineer

Retrieved on: 
Thursday, February 10, 2022
Technology, Satellite, Mobile, Wireless, Telecommunications, Networks, Internet, Lockheed, Veteran, NASA, STSS, Government, Missile Defense Agency, United States Secretary of the Air Force, Atmosphere, Solution, OWC, RF, Leadership, OWS, Communication, Engineering, Knowledge, Growth, General Atomics, Program, Intelligence, Loyola, Avenger, ASAT, Communications satellite

BridgeComm, Inc. , a leader in optical wireless communications (OWC) solutions and services, today announced that Rich Tortorelli will join the company as a chief systems engineer.

Key Points: 
  • BridgeComm, Inc. , a leader in optical wireless communications (OWC) solutions and services, today announced that Rich Tortorelli will join the company as a chief systems engineer.
  • Having developed, managed and executed 160 plus satellites with space-based constellations, Tortorelli brings thirty years of invaluable experience to BridgeComm to enhance its OWS space produce development efforts.
  • Prior to BridgeComm, Tortorelli served as the chief systems engineer at General Atomics, where he oversaw a NASA program, mentored and led a technical staff of 50 individuals and was responsible for systems end-to-end architecture, integration, testing, verification, launch and deployment, among many other responsibilities.
  • Tortorelli has worked for a variety of satellite companies developing and delivering satellites to customers such as the Missile Defense Agency, AirForce and NASA.

NSSA Statement on the Russian ASAT Test

Retrieved on: 
Tuesday, November 30, 2021
Policy, International Space Station, Government, Safety, Private sector, Acquisition, Alliance, National Reconnaissance Office, NSSA, First Nations in Ontario, Weapon, Budget, United States Intelligence Community, Solution, Astronaut, State, Department of Defense Appropriations Act, 2015, Chief of staff, View, Federation, Politics of the International Space Station, Risk, Joint Chiefs of Staff, National security, United States Space Force, Spacecraft, Friends, Intelligence, National Defense Authorization Act for Fiscal Year 2008, Intelligence Authorization Act, United Nations, Freedom, Appropriation bill, Congress, Multimedia, Element, ASAT, Department, Aggression, National, Risk management

ARLINGTON, Va., Nov. 30, 2021 /PRNewswire/ -- The National Security Space Association (NSSA) condemns Russia's recent test of a ground-based, kinetic energy anti-satellite (ASAT) weapon system against a target satellite in low Earth orbit.

Key Points: 
  • ARLINGTON, Va., Nov. 30, 2021 /PRNewswire/ -- The National Security Space Association (NSSA) condemns Russia's recent test of a ground-based, kinetic energy anti-satellite (ASAT) weapon system against a target satellite in low Earth orbit.
  • This irresponsible test created thousands of pieces of long-lived debris that jeopardize the flight safety of all nations' spacecraft and harm the sustainability of the space environment.
  • Diplomatic initiatives to create international opprobrium against debris-generating ASAT tests and establish norms of responsible space operations behaviors are important but insufficient.
  • To learn more about NSSA's stance on this topic, please contact Joe Dodd, Chair of the NSSA Board of Directors, or Steve Jacques, NSSA Executive Director, at [email protected] .

NASA Administrator Statement on Russian ASAT Test

Retrieved on: 
Monday, November 15, 2021
Anti-satellite weapon, EST, Johnson Space Center, Safety, Quest Joint Airlock, International Space Station, Leonardo (ISS module), NASA, ISS, Aircraft flight control system, International Space Station programme, Spacecraft, Risk assessment, Multimedia, Research, ASAT, Communications satellite

NASA Administrator Bill Nelson released the following statement about the incident:

Key Points: 
  • NASA Administrator Bill Nelson released the following statement about the incident:
    "Earlier today, due to the debris generated by the destructive Russian Anti-Satellite (ASAT) test, ISS astronauts and cosmonauts undertook emergency procedures for safety.
  • Their actions are reckless and dangerous, threatening as well the Chinese space station and the taikonauts on board.
  • An additional precautionary measure of sheltering the crew was executed for two passes through or near the vicinity of the debris cloud.
  • For updates about the International Space Station, its research, and its crew, visit:
    View original content to download multimedia: https://www.prnewswire.com/news-releases/nasa-administrator-statement-on...

Rise in Opioid & Alcohol Abuse During Pandemic Spawns Specialized Treatment Program

Retrieved on: 
Monday, October 25, 2021
COVID-19, CADC, BA, Smart TV, Disease, Signature program, Smith, AMAT, Signature, ASAT, Patient, View, Aftercare, Basketball, CEO, Multimedia, Tennis, Privacy, Pocono Mountains, Operation, Wi-Fi, Education, Pharmaceutical industry

SCOTRUN, Pa., Oct. 25, 2021 /PRNewswire/ -- Brookdale Premier Addiction Recovery, a leading provider in addiction treatment, announced the launch of the Brookdale Signature Program, an exclusive inpatient treatment program for executives and individuals requiring a more intensive, personalized treatment protocol.

Key Points: 
  • SCOTRUN, Pa., Oct. 25, 2021 /PRNewswire/ -- Brookdale Premier Addiction Recovery, a leading provider in addiction treatment, announced the launch of the Brookdale Signature Program, an exclusive inpatient treatment program for executives and individuals requiring a more intensive, personalized treatment protocol.
  • "I am very excited about the launch of our Signature Program and what it means for Brookdale," said Amy Durham, CEO.
  • The Signature Program will allow us to reach a broader scale of individuals struggling with a cunning and powerful disease."
  • Our Signature Program is designed to offer an exclusive and elevated experience to those looking for a tailored individualized treatment program, offering the highest quality of clinical and medical services."

Lilly's tirzepatide led to greater improvements in liver fat content compared to insulin degludec in adults with type 2 diabetes in SURPASS-3 MRI sub-study

Retrieved on: 
Thursday, September 30, 2021
Heart failure, LLY, Type 2 diabetes, MRI, Eli Lilly, European Association for the Study of Diabetes, ASAT, Private Securities Litigation Reform Act, Doctor of Philosophy, Heart failure with preserved ejection fraction, Patient, Multimedia, Centers for Disease Control and Prevention, Adipose tissue, Annual general meeting, Association, Population, Glucose, U.S. Securities and Exchange Commission, VAT, Metformin, EASD, Form 10-K, United States Department of Health and Human Services, Form, NASH, Twitter, Magnetic resonance imaging, Eli Lilly and Company, Human, Company, Liver disease, Human services, Institute, Incretin, Disease, GIP, Risk, GA, Center, Facebook, View, Research, Insulin, CNR, Safety, Fatty liver disease, NYSE, Conditional sentence, Pharmaceutical industry, Medical imaging, Fine chemical

"We are encouraged by the robust reductions in liver fat content and abdominal adipose tissue observed with all three doses of tirzepatide in this population of adults with type 2 diabetes and elevated liver fat content."

Key Points: 
  • "We are encouraged by the robust reductions in liver fat content and abdominal adipose tissue observed with all three doses of tirzepatide in this population of adults with type 2 diabetes and elevated liver fat content."
  • The subpopulation of adults with type 2 diabetes who participated in this sub-study had an overall baseline LFC of 15.7 percent.
  • Greater relative reduction from baseline in LFC (29.78%-47.11% across the three doses) compared to 11.17% for insulin degludec.
  • 1Cusi, K. The effects of tirzepatide on liver fat content and abdominal adipose tissue in patients with type 2 diabetes (SURPASS-3 MRI).